Document is current
Any future updates will be listed below
-
Authors
,
Fadnes, Lars T. http://orcid.org/0000-0001-8757-2092
Aas, Christer Frode
Vold, Jørn Henrik
Ohldieck, Christian
Leiva, Rafael Alexander
Chalabianloo, Fatemeh
Skurtveit, Svetlana
Lygren, Ole Jørgen
Dalgård, Olav
Vickerman, Peter
Midgard, Håvard
Løberg, Else-Marie
Johansson, Kjell Arne
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (269855)
Helse Vest Regionalt Helseføretak (Åpen prosjektstøtte)
- License Information
-
More Information
Article History
Received: 1 April 2019
Accepted: 25 October 2019
First Online: 8 November 2019
Competing interest
: The authors LTF, CFA, JHV, SS, CO, FC, EML, KAJ, have no competing interests. AL has received lecture and advisory fees from Gilead, GSK and MSD. OD has received research grants from and been in advisory board for MSD, Abbvie and Gilead. PV has received an unrestricted research grant off Gilead. HM has received lecture and advisory fees from Gilead, Abbvie and MSD.
: Except from use of a few hours of time from the participants and possible discomfort related to examinations such as blood sample collection, participation is not believed to be linked with substantial risks.The study has been approved by regional ethical committee (no. 2017/51/REK Vest, dated 29.03.2017/20.04.2017). The trial will be conducted in strict accordance with the Declaration of Helsinki and other international conventions and with GCP and GLP standards [, ]. Written informed consent and assent will be obtained from each participant.
: All authors have consented for publication.
